# Gilead Sciences, Inc. (GILD) — Q3-2016 Earnings Results

**Report date:** 2016-11-01 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/GILD/earnings/Q3-2016

## Post-Earnings Brief

### Headline

Gilead Sciences Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.75 | N/A | +0.22% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management highlighted the positive EPS surprise as a sign of operational efficiency. However, they did not provide specific revenue guidance, indicating a cautious outlook.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite the lack of revenue guidance.

> They emphasized ongoing efforts to enhance product offerings and market presence.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Gilead Sciences reported a positive EPS surprise, which may indicate effective cost management and operational efficiency. However, the lack of revenue figures and guidance leaves some uncertainty about future performance. Investors will need to monitor upcoming developments closely to gauge the company's trajectory.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/GILD/earnings/Q3-2016_